胸肌下假体置入相比胸肌前置入并不能预防乳房切除术后放疗相关并发症
回顾性队列研究比较2016至2019年接受乳房切除术后放疗(PMRT)并两阶段假体乳房再造(IBR)的患者,胸肌前与胸肌下假体置入在乳房相关并发症、假体感染、皮瓣坏死及假体取出率上均无显著差异。调整模型中,胸肌下置入与乳房相关并发症、假体感染或假体取出风险降低均无关。结论认为假体置入平面不能预测PMRT背景下IBR的并发症率。
要点
- 胸肌前与胸肌下置入的乳房相关并发症率分别为26.7%和21.8%,无显著差异(P=0.274)。
- 调整模型中胸肌下置入与乳房相关并发症风险降低无关(HR 0.75,95%CI 0.41-1.36)。
- 两阶段胸肌前IBR在PMRT背景下长期结局安全,并发症率与胸肌下相当。
核心结论
- 假体置入平面不能预测PMRT背景下IBR的并发症率。
- 两阶段胸肌前IBR提供安全的长期结局,术后并发症率与胸肌下IBR相当,即使在PMRT背景下。
研究设计与样本
- 回顾性队列研究,纳入2016至2019年接受乳房切除和PMRT并两阶段IBR的患者。
- 共172例患者、179个再造(胸肌前101个,胸肌下78个),平均随访39.7±14.4个月。
- 主要结局为乳房相关并发症(包括假体感染),次要结局为假体取出。
主要发现
- 胸肌前与胸肌下再造的乳房相关并发症率分别为26.7%和21.8%(P=0.274)。
- 假体感染率分别为18.8%和15.4%(P=0.307)。
- 皮瓣坏死率分别为5.0%和1.3%(P=0.232)。
- 假体取出率分别为20.8%和14.1%(P=0.117)。
- 调整模型中,与胸肌前置入相比,胸肌下置入与乳房相关并发症风险降低无关(HR 0.75;95%CI 0.41-1.36)、与假体感染风险降低无关(HR 0.73;95%CI 0.35-1.49)、与假体取出风险降低无关(HR 0.58;95%CI 0.28-1.19)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postmastectomy radiotherapy (PMRT) is associated with altered cosmetic outcomes and higher complication rates in implant-based breast reconstruction (IBR). Conventional wisdom suggests that muscle coverage is somewhat protective against PMRT-related complications. In this study, the authors compared surgical outcomes in patients who underwent two-stage prepectoral versus subpectoral IBR in the setting of PMRT. METHODS: The authors performed a retrospective cohort study of patients who underwent mastectomy and PMRT with two-stage IBR from 2016 to 2019. The primary outcome was breast-related complications, including device infection; the secondary outcome was device explantation. RESULTS: The authors identified 179 reconstructions (101 prepectoral and 78 subpectoral) in 172 patients with a mean follow-up time of 39.7 ± 14.4 months. There were no differences between the prepectoral and subpectoral reconstructions in rates of breast-related complications (26.7% and 21.8%, respectively; P = 0.274), device infection (18.8% and 15.4%, respectively; P = 0.307), skin flap necrosis (5.0% and 1.3%, respectively; P = 0.232), or device explantation (20.8% and 14.1%, respectively; P = 0.117). In adjusted models, compared with prepectoral device placement, subpectoral device placement was not associated with a lower risk of breast-related complications [hazard ratio (HR), 0.75; 95% confidence interval (CI), 0.41 to 1.36], device infection (HR, 0.73; 95% CI, 0.35 to 1.49), or device explantation (HR, 0.58; 95% CI, 0.28 to 1.19). CONCLUSIONS: Device placement plane was not predictive of complication rates in IBR in the setting of PMRT. Two-stage prepectoral IBR provides safe long-term outcomes with acceptable postoperative complication rates comparable to those with subpectoral IBR, even in the setting of PMRT. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Hassan AM, Asaad M, Morris N, et al. Subpectoral Implant Placement Is Not Protective against Postmastectomy Radiotherapy-Related Complications Compared to Prepectoral Placement. Plast Reconstr Surg. 2023. PMID: 37010459. doi:10.1097/PRS.0000000000010489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。